Is NMN regulated as a drug or supplement in Malaysia?

Supplement. NMN falls under the National Pharmaceutical Regulatory Agency's (NPRA) health supplement notification framework, the same channel that handles fish oil, glucosamine, multivitamins, and most over-the-counter wellness products. It is not classified as a prescription drug. It does not require a doctor's prescription to buy. Brands seeking legal sale in Malaysia must submit a notification dossier to NPRA covering ingredient identity, manufacturing facility, label claims, and stability data. On approval, NPRA issues an MAL number - typically formatted MAL followed by digits and an 'A' or 'NHC' suffix indicating the supplement category. You can verify any product's MAL status on the NPRA quest3plus portal at npra.gov.my. At the last editorial review, several NMN brands hold valid MAL numbers; others are sold via personal-import channels without local notification. The practical difference: MAL-notified products have a Malaysian importer of record, are eligible for retail sale at Watsons/Caring/Guardian, and any quality issues can be reported through formal NPRA channels. Personal-import products from brand-direct or Amazon do not have this accountability layer. NMN is not on Malaysia's controlled medicines list, is not subject to the Poisons Act 1952 schedules, and crosses customs as a dietary supplement. For sale to children, pregnant or breastfeeding women, this regulatory clearance does not equal medical endorsement - those groups still fall outside studied populations.

Why this matters for Malaysian buyers

NMN buying decisions in Malaysia involve a stack of considerations that don't always map to advice from US- or EU-focused sources: NPRA notification status, JAKIM halal certification (or its absence), tropical-climate storage realities, mall pharmacy versus Shopee Malaysia tradeoffs, and how local medical practitioners typically respond to questions about supplements outside their training. We answer questions like "Is NMN regulated as a drug or supplement in Malaysia?" through the lens of Malaysian buyer realities - not generic global guidance.

Verify the source

This individual Q&A is a supporting note, not an indexable authority article. Health-relevant claims should be refreshed against the linked primary or official sources before they are used for buying or medical discussions.

• NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR (2018)
• Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence (2018)
• NAD+ in aging, metabolism, and neurodegeneration (2015)
• National Pharmaceutical Regulatory Agency (NPRA) Malaysia - Quest3+ MAL Number Registry (2026)
• Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women (2022)

Adjacent tools

Need to act on this answer? Try the halal checker, the cost calculator, the stack builder, or the brand selector quiz - each tool turns advice into actionable output for your specific situation.

More questions? Browse the full Q&A library (10 categories) · See our main FAQ · Browse NMN brand comparisons · NR brand comparisons.